ARCHIVES

FDA Guidance for Public Comment at Advisory Committee Meetings

This article is from The Cancer Letter archive.

Vol. 36 No. 45 | December 10, 2010

Download PDF Visit The Full Archive

Related Articles

FDA Advisors Give Dox-SL Conditional Approval; Ok Zoladex

February 24, 1995

Cancer Prevention Fellowship Program Offers Enhancement

March 8, 1991

Letter to the Editor: “We Will Not Be Distracted From Our Mission”

February 1, 2013

Cancer Centers Program To Implement Most Changes Sought By review Group

December 13, 1996

Approvals and Applications: European Committee Signs Off On Paxene for KS reatment

March 5, 1999

AACR, ASCO Publish Reports Examining U.S. Cancer Care

April 4, 2014